Search Results - "Read, William L."

The use of a predictive statistical model to make a virtual control arm for a clinical trial by Switchenko, Jeffrey M, Heeke, Arielle L, Pan, Tony C, Read, William L

“…Randomized clinical trials compare participants receiving an experimental intervention to participants receiving standard of care (SOC). If one could predict…”
Get full text

Recurrent Epithelioid Hemangioma of the Bony Pelvis Responding to Propranolol by Broida, Sam, Reimer, Nickolas, Read, William L.

“…Epithelioid hemangioma is an uncommon benign vascular neoplasm which can arise in bone. Resection is generally curative, but occasionally lesions recur and…”
Get full text

Metastatic Alveolar Soft Part Sarcoma Responsive to Pazopanib after Progression through Sunitinib and Bevacizumab: Two Cases by Read, William L., Williams, Felicia

“…Alveolar soft part sarcoma (ASPS) is a rare soft tissue sarcoma with a propensity for lung metastases and indolent progression. ASPS is not responsive to…”
Get full text

Rare Delayed Ifosfamide Encephalopathy: A Case Report of Chemotherapeutic Neurotoxicity by Menon, Ambika, Enunwa, Chidiebele A., Read, William L., James, Kyle P.

“…Abstract Introduction: Neurotoxicity is a well-documented side effect of ifosfamide chemotherapy. The presentation includes hallucinations, seizures,…”
Get full text

Recurrent Meningioma of the Cervical Spine, Successfully Treated with Liposomal Doxorubicin by Read, William L., Williams, Felicia

“…There is no standard systemic treatment for persons with recurrent meningioma who have exhausted surgery and radiation options. Liposomal doxorubicin is a…”
Get full text

Differential Prognostic Impact of Comorbidity by READ, William L, TIERNEY, Ryan M, PAGE, Nathan C, COSTAS, Irene, GOVINDAN, Ramaswamy, SPITZNAGEL, Edward L. J, PICCIRILLO, Jay F

“…Cancer patients with concurrent comorbid conditions have worse outcomes than patients with no comorbidities. We hypothesized that the prognostic impact of…”
Get full text

Metastatic Angiosarcoma with Kasabach-Merritt Syndrome Responsive to Gemcitabine and Vinorelbine after Failure of Liposomal Doxorubicin and Paclitaxel: A Case Report by Read, William L., Williams, Felicia

“…Kasabach-Merritt syndrome (KMS) describes a consumptive coagulopathy associated with certain vascular tumors. It is thought that platelets are destroyed as…”
Get full text

Norethindrone substituted for megestrol in the treatment of metastatic endometrial carcinoma: Three cases by Read, William L., Trivedi, Sumita, Williams, Felicia

“…Megestrol is an effective palliative treatment for endometrial carcinoma. Some persons with progestin-responsive cancer continue on hormonal therapy for months…”
Get full text

The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database by Read, William L, Page, Nathan C, Tierney, Ryan M, Piccirillo, Jay F, Govindan, Ramaswamy

“…Bronchioloalveolar carcinoma of the lung (BAC) is a subtype of adenocarcinoma of the lung. Although traditionally grouped with other non-small cell lung…”
Get full text

A unique case of an indolent CD56-positive T-cell lymphoproliferative disorder of the gastrointestinal tract: a lesion potentially misdiagnosed as natural killer/T-cell lymphoma by McElroy, Michele K., MD, Read, William L., MD, Harmon, Gregory S., MD, Weidner, Noel, MD

“…Abstract Primary intestinal natural killer (NK)/T-cell lymphoma (nasal-type) and enteropathy-associated T-cell lymphoma, type II, are CD56-positive…”
Get full text

Atezolizumab for Advanced Alveolar Soft Part Sarcoma by Chen, Alice P., Sharon, Elad, O’Sullivan-Coyne, Geraldine, Moore, Nancy, Foster, Jared C., Hu, James S., Van Tine, Brian A., Conley, Anthony P., Read, William L., Riedel, Richard F., Burgess, Melissa A., Glod, John, Davis, Elizabeth J., Merriam, Priscilla, Naqash, Abdul R., Fino, Kristin K., Miller, Brandon L., Wilsker, Deborah F., Begum, Asma, Ferry-Galow, Katherine V., Deshpande, Hari A., Schwartz, Gary K., Ladle, Brian H., Okuno, Scott H., Beck, Jill C., Chen, James L., Takebe, Naoko, Fogli, Laura K., Rosenberger, Christina L., Parchment, Ralph E., Doroshow, James H.

“…Alveolar soft part sarcoma is a rare mesenchymal tumor with characteristic gene rearrangement that creates an ASPL–TFE3 fusion protein. In a phase 2 study,…”
Get full text

A randomized, open‐label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft‐tissue sarcoma by Somaiah, Neeta, Van Tine, Brian Andrew, Wahlquist, Amy E., Milhem, Mohammed M., Hill, Elizabeth G., Garrett‐Mayer, Elizabeth, Armeson, Kent E., Schuetze, Scott M., Meyer, Christian F., Reuben, Daniel Y., Elias, Anthony D., Read, William L., Chawla, Sant P., Kraft, Andrew S.

“…Background Therapeutic options for patients with advanced soft‐tissue sarcoma (STS) are limited. The goal of the current phase 2 study was to examine the…”
Get full text

A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery by Rosenbaum, Evan, Chugh, Rashmi, Ryan, Christopher W., Agulnik, Mark, Milhem, Mohammed M., George, Suzanne, Jones, Robin L., Chmielowski, Bartosz, Van Tine, Brian A., Tawbi, Hussein, Elias, Anthony D., Read, William L., Budd, G. Thomas, Qin, Li-Xuan, Rodler, Eve T., Hirman, Joe, Weiden, Paul, Bennett, Cathryn M., Livingston, Philip O., Ragupathi, Govind, Hansen, David, D'Angelo, Sandra P., Tap, William D., Schwartz, Gary K., Maki, Robert G., Carvajal, Richard D.

“…Recurrence after resection of metastatic sarcoma is common. The gangliosides GM2, GD2 and GD3 are strongly expressed across sarcoma subtypes. We hypothesised…”
Get full text

Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas by Holdhoff, Matthias, Ye, Xiaobu, Supko, Jeffrey G, Nabors, Louis B, Desai, Arati S, Walbert, Tobias, Lesser, Glenn J, Read, William L, Lieberman, Frank S, Lodge, Martin A, Leal, Jeffrey, Fisher, Joy D, Desideri, Serena, Grossman, Stuart A, Wahl, Richard L, Schiff, David

“…Mibefradil (MIB), previously approved for treatment of hypertension, is a selective T-type calcium channel blocker with preclinical activity in high-grade…”
Get full text

Dose–response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulin by Lorza, Andres M. Arias, Ravi, Harshan, Philip, Rohit C., Galons, Jean-Philippe, Trouard, Theodore P., Parra, Nestor A., Von Hoff, Daniel D., Read, William L., Tibes, Raoul, Korn, Ronald L., Raghunand, Natarajan

“…The vascular disrupting agent crolibulin binds to the colchicine binding site and produces anti-vascular and apoptotic effects. In a multisite phase 1 clinical…”
Get full text

Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression by Huang, Raymond Y, Unadkat, Prashin, Bi, Wenya Linda, George, Elizabeth, Preusser, Matthias, McCracken, Jay D, Keen, Joseph R, Read, William L, Olson, Jeffrey J, Seystahl, Katharina, Le Rhun, Emilie, Roelcke, Ulrich, Koeppen, Susanne, Furtner, Julia, Weller, Michael, Raizer, Jeffrey J, Schiff, David, Wen, Patrick Y

“…Abstract Background Meningiomas are the most common primary brain tumors in adults. Due to their variable growth rates and irregular tumor shapes, response…”
Get full text

Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma by McCracken, D. Jay, Celano, Emma C., Voloschin, Alfredo D., Read, William L., Olson, Jeffrey J.

“…The average survival time for patients with recurrent glioblastoma is between 5 and 9 months. Phase I and II trials have shown a modest survival benefit with…”
Get full text

Reciprocal auxiliary partial liver transplant for inborn noncirrhotic metabolic diseases by Read, William L

Get full text

Severe interstitial pneumonitis associated with docetaxel administration by Read, William L., Mortimer, Joanne E., Picus, Joel

“…BACKGROUND Interstitial pneumonitis has not been reported as a toxicity of docetaxel. The authors report the presentation and natural history of four patients…”
Get full text

Squamous cell carcinomas of the skin responsive to erlotinib: 5 cases by Read, William L., Brumund, Kevin T., Weisman, Robert A., Nguyen, Angel Q.

Get full text